Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals
Financial Results:
Tatva Chintan Pharma Chem Ltd reported Revenues for Q4FY24 of ₹98.27 Crores down from ₹124.51 Crore year on year, a fall of 21.07%.
Total Expenses for Q4FY24 of ₹89.11 Crores down from ₹113.97 Crores year on year, a fall of 21.81%.
Consolidated Net Profit of ₹9.61 Crores down 43.3% from ₹16.95 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.11, down 46.27% from ₹7.65 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.